167
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Impact of Physical Inactivity on the Risk of Disability and Hospitalization in Older Patients with Advanced Lung Cancer

, ORCID Icon, , , , , , , , , , , , , , ORCID Icon, & show all
Pages 1521-1532 | Published online: 21 Jun 2021

References

  • Takayuki N, Keiko T, Junji U, et al. Advanced non-small-cell lung cancer in elderly patients: patient features and therapeutic management. Biomed Res Int. 2018;30:8202971.
  • Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288–300. doi:10.21037/tlcr.2016.06.07
  • Presley CJ, Reynolds CH, Langer CJ. Caring for the older population with advanced lung cancer. Am Soc Clin Oncol Educ Book. 2017;37(37):587–596. doi:10.1200/EDBK_179850
  • Ministry of Health, Labour and Welfare [homepage on the internet]. Estimates of medical care expenditure, summary for 2018. Available from: https://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/18/index.html. Accessed January 3, 2021.
  • Cruz-Jentoft AJ, Bahat G, Bauer J, et al; for European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. doi:10.1093/ageing/afz046
  • Sattar S, Alibhai SM, Spoelstra SL, Fazelzad R, Puts MT. Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatment. Support Care Cancer. 2016;24(10):4459–4469. doi:10.1007/s00520-016-3342-8
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al.; for European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
  • Asmis TR, Ding K, Seymour L, et al.; for National Cancer Institute of Canada Clinical Trials Group. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of national cancer institute of Canada clinical trials group trials. J Clin Oncol. 2008;26(1):54–59. doi:10.1200/JCO.2007.12.8322
  • Gioulbasanis I, Georgoulias P, Vlachostergios PJ, et al. Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis. Lung Cancer. 2011;74(3):516–520. doi:10.1016/j.lungcan.2011.05.009
  • Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr. 2010;91(4):1133S–1137S. doi:10.3945/ajcn.2010.28608C
  • Kimura M, Naito T, Kenmotsu H, et al. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer. 2015;23(6):1699–1708. doi:10.1007/s00520-014-2534-3
  • Naito T, Okayama T, Aoyama T, et al. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a Prospective Longitudinal Observational Study. BMC Cancer. 2017;17(1):800. doi:10.1186/s12885-017-3795-2
  • Lowe SS, Danielson B, Beaumont C, Watanabe SM, Baracos VE, Courneya KS. Associations between objectively measured physical activity and quality of life in cancer patients with brain metastases. J Pain Symptom Manage. 2014;48(3):322–332. doi:10.1016/j.jpainsymman.2013.10.012
  • Morikawa A, Naito T, Sugiyama M, et al. Impact of cancer cachexia on hospitalization-associated physical inactivity in elderly patients with advanced non-small-cell lung cancer. Asia Pac J Oncol Nurs. 2018;5(4):377–382. doi:10.4103/apjon.apjon_20_18
  • Fearon KC. Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer. 2008;44(8):1124–1132. doi:10.1016/j.ejca.2008.02.033
  • Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247. doi:10.1016/j.ejca.2008.10.026
  • Kumahara H, Schutz Y, Ayabe M, et al. The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry. Br J Nutr. 2004;91(2):235–243. doi:10.1079/BJN20031033
  • Yasunaga A, Togo F, Watanabe E, et al. Sex, age, season, and habitual physical activity of older Japanese: the Nakanojo Study. J Aging Phys Act. 2008;16(1):3–13. doi:10.1123/japa.16.1.3
  • Naito T, Mitsunaga S, Miura S, et al. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle. 2019;10(1):73–83. doi:10.1002/jcsm.12351
  • Mouri T, Naito T, Morikawa A, et al. Promotion of behavioral change and the impact on quality of life in elderly patients with advanced cancer: a physical activity intervention of the multimodal nutrition and exercise treatment for advanced cancer program. Asia Pac J Oncol Nurs. 2018;5(4):383–390. doi:10.4103/apjon.apjon_21_18
  • Pate RR, Pratt M, Blair SN, et al. Physical activity and public health. A recommendation from the centers for disease control and prevention and the american college of sports medicine. JAMA. 1995;273(5):402–407. doi:10.1001/jama.1995.03520290054029
  • Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997–1006. doi:10.1139/H08-075
  • Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539–1547. doi:10.1200/JCO.2012.45.2722
  • Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495. doi:10.1016/S1470-2045(10)70218-7
  • Singh SJ, Puhan MA, Andrianopoulos V, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1447–1478. doi:10.1183/09031936.00150414
  • Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47(12):1019–1024. doi:10.1136/thx.47.12.1019
  • Perna FM, Coa K, Troiano RP, et al. Muscular grip strength estimates of the U.S. population from the national health and nutrition examination survey 2011–2012. J Strength Cond Res. 2016;30(3):867–874. doi:10.1519/JSC.0000000000001104
  • Naito T. Evaluation of the true endpoint of clinical trials for cancer cachexia. Asia Pac J Oncol Nurs. 2019;6(3):227–233. doi:10.4103/apjon.apjon_68_18
  • Nelson W. Confidence limits for recurrence data: applied to cost or number of product repairs. Technometrics. 1995;37(2):147–157.
  • Humphries KH, Pu A, Gao M, Carere RG, Pilote L. Angina with “normal” coronary arteries: sex differences in outcomes. Am Heart J. 2008;155(2):375–381. doi:10.1016/j.ahj.2007.10.019
  • Smedira NG, Hoercher KJ, Lima B, et al. Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. JACC Heart Fail. 2013;1(1):31–39. doi:10.1016/j.jchf.2012.11.001
  • Maemondo M, Inoue A, Kobayashi K, et al.; for North-East Japan Study Group. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362(25):2380–2388. doi:10.1056/NEJMoa0909530
  • Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P; for International Staging Committee and Participating Institutions. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition. J Thorac Oncol. 2008;3(5):457–466. doi:10.1097/JTO.0b013e31816de2b8
  • Granger CL, McDonald CF, Irving L, et al. Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer. 2014;83(2):292–299. doi:10.1016/j.lungcan.2013.11.014
  • Fujisawa D, Temel JS, Greer JA, et al. Actigraphy as an assessment of performance status in patients with advanced lung cancer. Palliat Support Care. 2019;17(5):574–578. doi:10.1017/S1478951518001074
  • Ohri N, Halmos B, Bodner WR, et al. Daily step counts: a new prognostic factor in locally advanced non-small cell lung cancer? Int J Radiat Oncol Biol Phys. 2019;105(4):745–751. doi:10.1016/j.ijrobp.2019.07.055
  • Norman K, Otten L. Financial impact of sarcopenia or low muscle mass - A short review. Clin Nutr. 2019;38(4):1489–1495. doi:10.1016/j.clnu.2018.09.026
  • Vermillion SA, Hsu FC, Dorrell RD, Shen P, Clark CJ. Modified frailty index predicts postoperative outcomes in older gastrointestinal cancer patients. J Surg Oncol. 2017;115(8):997–1003. doi:10.1002/jso.24617
  • Murphy CC, Incalcaterra JR, Albright HW, Correa AM, Swisher SG, Hofstetter WL. Pretreatment patient comorbidity and tobacco use increase cost and risk of postoperative complications after esophagectomy at a high-volume cancer center. J Oncol Pract. 2013;9(5):233–239. doi:10.1200/JOP.2013.001047
  • Ohri N, Kabarriti R, Bodner WR, et al. Continuous activity monitoring during concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2017;97(5):1061–1065. doi:10.1016/j.ijrobp.2016.12.030
  • Douma JAJ, de Beaufort MB, Kampshoff CS, et al. Physical activity in patients with cancer: self-report versus accelerometer assessments. Support Care Cancer. 2020;28(8):3701–3709. doi:10.1007/s00520-019-05203-3
  • Granger CL, Parry SM, Denehy L. The self-reported Physical Activity Scale for the Elderly (PASE) is a valid and clinically applicable measure in lung cancer. Support Care Cancer. 2015;23(11):3211–3218. doi:10.1007/s00520-015-2707-8
  • Giné-Garriga M, Roqué-Fíguls M, Coll-Planas L, Sitjà-Rabert M, Salvà A. Physical exercise interventions for improving performance-based measures of physical function in community-dwelling, frail older adults: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2014;95(4):753–769.e3. doi:10.1016/j.apmr.2013.11.007
  • Avancini A, Tregnago D, Rigatti L, et al. Factors influencing physical activity in cancer patients during oncological treatments: a Qualitative Study. Integr Cancer Ther. 2020;19:1534735420971365. doi:10.1177/1534735420971365
  • Avancini A, Sartori G, Gkountakos A, et al. Physical activity and exercise in lung cancer care: will promises be fulfilled? Oncologist. 2019; theoncologist.2019-0463.
  • Heywood R, McCarthy AL, Skinner TL. Efficacy of exercise interventions in patients with advanced cancer: a systematic review. Arch Phys Med Rehabil. 2018;99(12):2595–2620. doi:10.1016/j.apmr.2018.04.008
  • Dittus KL, Gramling RE, Ades PA. Exercise interventions for individuals with advanced cancer: a systematic review. Prev Med. 2017;104:124–132. doi:10.1016/j.ypmed.2017.07.015
  • Grande GD, Oliveira CB, Morelhão PK, et al. Interventions promoting physical activity among older adults: a systematic review and meta-analysis. Gerontologist. 2020;60(8):583–599. doi:10.1093/geront/gnz167
  • Schaffer K, Panneerselvam N, Loh KP, et al. Systematic review of randomized controlled trials of exercise interventions using digital activity trackers in patients with cancer. J Natl Compr Canc Netw. 2019;17(1):57–63. doi:10.6004/jnccn.2018.7082
  • Miura S, Naito T, Mitsunaga S, et al. A randomized Phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO Study protocol. BMC Cancer. 2019;19(1):528. doi:10.1186/s12885-019-5762-6